Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Entrada Therapeutics Inc., 3 years.
Entrada Therapeutics Inc.
Director
Amylyx Pharmaceuticals Inc.
Director
Abeona Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 20, 2026 | Entrada Therapeutics Inc. | Open-market purchase | +5,000 | $5.86 | $29,300 |
| Jan 26, 2026 | Abeona Therapeutics Inc. | Grant or award | +37,313 | — | — |
| Mar 20, 2025 | Amylyx Pharmaceuticals Inc. | Open-market purchase | +10,000 | $3.70 | $37,000 |
| Jan 31, 2025 | Abeona Therapeutics Inc. | Grant or award | +36,101 | — | — |
| Aug 13, 2024 | Abeona Therapeutics Inc. | Grant or award | +11,044 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.